| Aplastic anemia NS Young New England Journal of Medicine 379 (17), 1643-1656, 2018 | 638 | 2018 |
| Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy TE Witzig, PT Silberstein, CL Loprinzi, JA Sloan, PJ Novotny, JA Mailliard, ... Journal of clinical oncology 23 (12), 2606-2617, 2005 | 276 | 2005 |
| Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7 A Grothey, DA Nikcevich, JA Sloan, JW Kugler, PT Silberstein, T Dentchev, ... Journal of Clinical Oncology 29 (4), 421-427, 2011 | 251 | 2011 |
| Controlled-release oxycodone compared with controlled-release morphine in the treatment of cancer pain: a randomized, double-blind, parallel-group study P Mucci-LoRusso, BS Berman, PT Silberstein, ML Citron, L Bressler, ... European Journal of Pain 2 (3), 239-249, 1998 | 239 | 1998 |
| Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial AR Moraska, A Sood, SR Dakhil, JA Sloan, D Barton, PJ Atherton, JJ Suh, ... Journal of clinical oncology 28 (23), 3673-3679, 2010 | 213 | 2010 |
| Epidemiology of thyroid cancer: a review of the National Cancer Database, 2000-2013 E Olson, G Wintheiser, KM Wolfe, J Droessler, PT Silberstein Cureus 11 (2), 2019 | 169 | 2019 |
| Darbepoetin alfa 300 or 500 μg once every 3 weeks with or without intravenous iron in patients with chemotherapy‐induced anemia M Auerbach, PT Silberstein, RT Webb, S Averyanova, TE Ciuleanu, ... American journal of hematology 85 (9), 655-663, 2010 | 121 | 2010 |
| Effect of palliative care services on the aggressiveness of end-of-life care in the Veteran's Affairs cancer population WI Gonsalves, T Tashi, J Krishnamurthy, T Davies, S Ortman, R Thota, ... Journal of palliative medicine 14 (11), 1231-1235, 2011 | 102 | 2011 |
| The epidemiology and survivorship of clear cell sarcoma: a National Cancer Database (NCDB) review MI Gonzaga, L Grant, C Curtin, J Gootee, P Silberstein, E Voth Journal of Cancer Research and Clinical Oncology 144, 1711-1716, 2018 | 59 | 2018 |
| Association between race and survival of patients with non–small-cell lung cancer in the United States veterans affairs population AK Ganti, SP Subbiah, A Kessinger, WI Gonsalves, PT Silberstein, ... Clinical lung cancer 15 (2), 152-158, 2014 | 50 | 2014 |
| Effect of intravenous calcium and magnesium (IV CaMg) on oxaliplatin-induced sensory neurotoxicity (sNT) in adjuvant colon cancer: results of the phase III placebo-controlled … DA Nikcevich, A Grothey, JA Sloan, JW Kugler, PT Silberstein, T Dentchev, ... Journal of Clinical Oncology 26 (15_suppl), 4009-4009, 2008 | 50 | 2008 |
| Socioeconomic status and survival for patients with melanoma in the United States: an NCDB analysis JL Sitenga, G Aird, A Ahmed, R Walters, PT Silberstein International journal of dermatology 57 (10), 1149-1156, 2018 | 48 | 2018 |
| Darbepoetin alfa administered every three weeks is effective for the treatment of chemotherapy-induced anemia R Boccia, IA Malik, V Raja, S Kahanic, R Liu, T Lillie, D Tomita, B Clowney, ... The Oncologist 11 (4), 409-417, 2006 | 47 | 2006 |
| Chemotherapy use in stage III colon cancer: a National Cancer Database analysis S Upadhyay, S Dahal, VR Bhatt, N Khanal, PT Silberstein Therapeutic advances in medical oncology 7 (5), 244-251, 2015 | 41 | 2015 |
| Clinicopathologic factors associated with lymph node retrieval in resectable colon cancer: a Veterans' Affairs Central Cancer Registry (VACCR) database analysis WI Gonsalves, S Kanuri, T Tashi, I Aldoss, A Sama, I Al‐Howaidi, A Ganta, ... Journal of Surgical Oncology 104 (6), 667-671, 2011 | 40 | 2011 |
| Steroids decrease granulocyte membrane fluidity, while phorbol ester increases membrane fluidity: studies using electron paramagnetic resonance HR Lamche, PT Silberstein, AC Knabe, DD Thomas, HS Jacob, ... Inflammation 14, 61-70, 1990 | 37 | 1990 |
| Hereditary cancer syndromes: utilizing DNA repair deficiency as therapeutic target G Goyal, T Fan, PT Silberstein Familial cancer 15, 359-366, 2016 | 35 | 2016 |
| Systemic therapy in stage IV pancreatic cancer: a population-based analysis using the National Cancer Data Base N Khanal, S Upadhyay, S Dahal, VR Bhatt, PT Silberstein Therapeutic Advances in Medical Oncology 7 (4), 198-205, 2015 | 35 | 2015 |
| Lorazepam, diphenhydramine, and haloperidol transdermal gel for rescue from chemotherapy-induced nausea/vomiting: results of two pilot trials. J Bleicher, A Bhaskara, T Huyck, S Constantino, A Bardia, CL Loprinzi, ... The journal of supportive oncology 6 (1), 27-32, 2008 | 35 | 2008 |
| Impact of siltuximab on patient-related outcomes in multicentric Castleman’s disease J Sitenga, G Aird, A Ahmed, PT Silberstein Patient Related Outcome Measures, 35-41, 2018 | 33 | 2018 |
